China Resourcesnjiu Medical & Pharmaceutical Co's quarterly market cap
declined
from Sep. 2023 (¥49,528 Mil) to Dec. 2023 (¥49,142 Mil) but then
increased
from Dec. 2023 (¥49,142 Mil) to Mar. 2024 (¥51,277 Mil).
China Resourcesnjiu Medical & Pharmaceutical Co's annual market cap
increased
from Dec. 2021 (¥33,518 Mil) to Dec. 2022 (¥46,264 Mil) and
increased
from Dec. 2022 (¥46,264 Mil) to Dec. 2023 (¥49,142 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. China Resourcesnjiu Medical & Pharmaceutical Co's Enterprise Value for Today is ¥52,652 Mil.
China Resourcesnjiu Medical & Pharmaceutical Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
China Resourcesnjiu Medical & Pharmaceutical Co Market Cap Chart
China Resourcesnjiu Medical & Pharmaceutical Co Annual Data
Competitive Comparison of China Resourcesnjiu Medical & Pharmaceutical Co's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, China Resourcesnjiu Medical & Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Resourcesnjiu Medical & Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry
* The bar in red indicates where China Resourcesnjiu Medical & Pharmaceutical Co's Market Cap falls into.
China Resourcesnjiu Medical & Pharmaceutical Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
China Resourcesnjiu Medical & Pharmaceutical Co Market Cap Related Terms
Thank you for viewing the detailed overview of China Resourcesnjiu Medical & Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Business Description
China Resources Sanjiu Medical & Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in the research and development, production and sale of pharmaceutical products, healthcare products, and medical appliances under the brand name 999, which includes OTC, antibiotic and raw material drug. The other brands under which the company offers its products are Lee King, Shunfeng, and Tianhe. The company's core business is located in OTC and Chinese medicine prescription drugs, OTC core products in the cold, gastrointestinal, skin, pediatric, cough and orthopedic drugs occupy a higher market share; prescription drug products in traditional Chinese medicine formula granules, cardiovascular and cerebrovascular, anti-tumor in the field of anti-infection and other areas.
China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:000999 has been successfully added to your 